Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Ocular benzalkonium chloride exposure: problems and solutions
2021128 citationsMichael H. Goldstein, Srilatha Vantipalli et al.profile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Michael H. Goldstein
Since
Specialization
Citations
This map shows the geographic impact of Michael H. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Goldstein more than expected).
Fields of papers citing papers by Michael H. Goldstein
This network shows the impact of papers produced by Michael H. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Goldstein. The network helps show where Michael H. Goldstein may publish in the future.
Co-authorship network of co-authors of Michael H. Goldstein
This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Goldstein.
A scholar is included among the top collaborators of Michael H. Goldstein based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Michael H. Goldstein. Michael H. Goldstein is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Goldstein, Michael H., et al.. (2021). The many functions of vocal learning. Philosophical Transactions of the Royal Society B Biological Sciences. 376(1836). 20200235–20200235.16 indexed citations
6.
Goldberg, Damien F., et al.. (2021). Phase 1 Study of an Intracameral Travoprost Hydrogel-based Implant for the Treatment of POAG and Ocular Hypertension. Investigative Ophthalmology & Visual Science. 62(8). 2765–2765.1 indexed citations
7.
Wong, James, Andrew Chang, Robyn H. Guymer, et al.. (2021). Phase 1 Study of an Intravitreal Axitinib Hydrogel-based Implant for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD). Investigative Ophthalmology & Visual Science. 62(8). 218–218.11 indexed citations
8.
Cheung, Matthew C., et al.. (2021). Ocular Pharmacokinetics of OTX-DED, a Sustained-release Intracanalicular Insert Delivering Dexamethasone, in a Canine Model. Investigative Ophthalmology & Visual Science. 62(8). 1323–1323.1 indexed citations
Vantipalli, Srilatha, et al.. (2020). Evaluating Safety and Pharmacokinetics of OTX-CSI, a Sustained Release Intracanalicular Cyclosporine Insert in Beagles. Investigative Ophthalmology & Visual Science. 61(7). 3258–3258.1 indexed citations
11.
Goldstein, Michael H., et al.. (2020). Evaluating Safety, Tolerability and Efficacy of an Intracameral Hydrogel-Based Travoprost Implant in Subjects with Glaucoma - Phase 1 Trial. Investigative Ophthalmology & Visual Science. 61(7). 4266–4266.7 indexed citations
12.
Metzinger, Jamie Lynne, et al.. (2019). Pharmacokinetics of OTX-CSI, a Sustained Release Cyclosporine Intracanalicular Insert in Beagles. Investigative Ophthalmology & Visual Science. 60(9). 285–285.1 indexed citations
13.
Metzinger, Jamie Lynne, et al.. (2019). Effect of OTX-TIC, a Sustained Release Travoprost Intracameral Implant on Central Corneal Thickness in Beagles. Investigative Ophthalmology & Visual Science. 60(9). 3345–3345.1 indexed citations
14.
Metzinger, Jamie Lynne, et al.. (2019). Pharmacokinetics of OTX-TIC, a Sustained Release Travoprost Intracameral Implant in Rabbits. Investigative Ophthalmology & Visual Science. 60(9). 3777–3777.1 indexed citations
15.
Metzinger, Jamie Lynne, et al.. (2018). Efficacy and Pharmacokinetics of a Sustained Release Travoprost Intracameral Hydrogel Implant in Beagle Dogs. Investigative Ophthalmology & Visual Science. 59(9). 1245–1245.3 indexed citations
16.
Metzinger, Jamie Lynne, et al.. (2018). Effectiveness of Sustained Release TKI Hydrogel Combined with Bevacizumab in a VEGF Induced Retinal Leakage Model Through 12 Months. Investigative Ophthalmology & Visual Science. 59(9). 245–245.1 indexed citations
Goldstein, Michael H., et al.. (2016). Phase 3 Multi-Center Trial Evaluating the Efficacy, Safety and Tolerability of Isunakinra (EBI-005) in Subjects with Moderate to Severe Allergic Conjunctivitis. Investigative Ophthalmology & Visual Science. 57(12). 307–307.4 indexed citations
20.
Tubridy, Karen L., et al.. (2015). Clinical Development of EBI-005, a Novel Interleukin-1 Receptor Inhibitor, for Patients with Ocular Surface Inflammation. Investigative Ophthalmology & Visual Science. 56(7). 4488–4488.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.